Overview
HIV-1 is the predominant type of the human immunodeficiency virus and the cause of the majority of HIV infections worldwide. A lentivirus of the retrovirus family, it carries a positive-sense RNA genome that, after entry via CD4 and a chemokine co-receptor, is reverse-transcribed by viral reverse transcriptase and integrated into host DNA; maturation of new virions depends on cleavage of viral polyproteins by HIV-1 protease. These enzymatic steps, reverse transcription, integration, and protease-mediated maturation, are the principal targets of antiretroviral drugs, and the virus's high replication and mutation rates drive antigenic diversity and the emergence of drug resistance. HIV-1 progressively depletes CD4-positive T cells, producing immunodeficiency, and is transmitted through blood, sexual contact, and from mother to child. The peer-reviewed research collected here in the journal's HIV and infectious-disease corpus reflects these themes, including antioxidant status, CD4 count and viral load in patients on combination antiretroviral therapy, T-cell vaccination hypotheses for eliciting HIV-1-specific responses, molecular docking of phytocompounds against HIV-1 reverse transcriptase and protease, clinical and immunological effects of botanical preparations in HIV-1-seropositive individuals, phytochemical approaches proposed to arrest HIV-1 progression, HIV self-testing and pre-exposure prophylaxis adherence, and false-positive rapid testing. Together they situate HIV-1 within its molecular biology, treatment targets, and prevention strategies.
Research published in this journal
12 peer-reviewed articles, ranked by relevance. Each links to its DOI.
Raising HLA-E-Restricted HIV-1-Specific Immune Responses Through T Cell Vaccination: A Hypothesis
Docking Studies of HIV-1 Reverse Transcriptase and HIV-1 Protease with Phytocompounds of Carissa Carandas L.
Clinical and Immunological Beneficial Effects of Phyto V7 Consumption by HIV-1 Seropositive Individuals
Phytochemicals May Arrest HIV-1 Progression
Painful Lesions in an HIV-1 Seropositive African Woman.
Exploring HIV Self-Testing: Barriers and Facilitators among Undergraduate Students
Predictors of Adherence to Pre-Exposure Prophylaxis among Female Sex Workers in South-Western Nigeria
Risk Factors of HIV among Voluntary Counseling and Testing Centers Clients, Elgenina Town, West Darfur, Sudan.
Invivo Impact of Malaria and HIV Co-Infection on CD4 Cell Count of Infected Patients of Niger Delta Extraction
Physical Activity and Risk Factors Screening for Ischaemic Heart Disease in South African Individuals Living with HIV
Report of a False Positive Rapid HIV Test Due to Hepatitis A in a U.S. Army Soldier
How this research is being cited
The 12 articles above have been cited 23 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.
-
2026 · BMC Public Health
-
2025 · HIV Medicine
-
2025 · The Natural Products Journal
-
2025 · HIV Medicine
-
2024 · Case Reports in Clinical Medicine
-
2024 · World Journal of Advanced Research and Reviews
-
2024 · Case Reports in Clinical Medicine
-
2024 · Journal of Microbiology & Experimentation
A sample of recent works citing this journal's research on Hiv-1, linking to each citing work.